Government medical faculty in Telangana complain over poor pay, staff crunch
HYDERABAD: Government doctors across Telangana, particularly those in medical colleges, have voiced dissatisfaction over the continued neglect of long-pending issues, despite a change in government and administration.
Doctors said they had hoped for improved working conditions, but now feel overlooked, demotivated, and undervalued. Their key concerns include excessive interference and micromanagement by district authorities, unequal pay structures, inadequate infrastructure, and severe staff shortages in government medical colleges.
A senior faculty member stated that many doctors are losing motivation due to mistreatment by political figures and higher authorities, which is not only demeaning but also affecting patient care and academics.
Dr Kiran Madhala, secretary general of the Telangana Teaching Government Doctors Association, told TNIE, 'There is a growing sense of disillusionment among teaching faculty. Many of us joined with a sense of purpose, but years of neglect have left us demotivated. Despite repeated appeals, no concrete action has been taken.'
He added that while the number of medical colleges has increased, most remain severely understaffed, with the burden falling on existing faculty — something the administration continues to ignore.
Doctors also highlighted other critical issues such as no incentives or promotions for those serving in under-resourced districts, no DME-level promotions despite repeated requests, leading to career stagnation, lack of a transparent or responsive mechanism to communicate with DME or health secretariat and decline in academic standards at top institutions like Osmania, Gandhi and Kakatiya medical colleges due to years of neglect.
Adding to their concerns, the state health department's plan to introduce geo-tagged, face-based Aadhaar authentication for faculty attendance has sparked outrage.
While the National Medical Commission has mandated face-based Aadhaar authentication for faculty attendance from May 1, doctors argue that geo-tagging infringes on privacy.
Dr Kiran Bollepaka, TTGDA president, noted that while face-based systems are similar to existing biometric attendance, 'geo-tagging is a breach of privacy. There are better ways to ensure accountability without excessive scrutiny,' he said.
Aadhaar-based face authentication soon
All government health centres will soon implement face-based Aadhaar authentication to ensure staff regularity and accountability. DoPH Ravinder Naik stated that PHCs, UPHCs and basti dawakhanas will adopt the system soon
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New Indian Express
an hour ago
- New Indian Express
PG medicos launch stir over non-payment of stipend in Telangana
HYDERABAD: Postgraduate interns at Dr Patnam Mahender Reddy Institute of Medical Sciences (PMRIMS) in Chevella launched a strike on Monday, demanding the release of their long-pending stipends. For several months, students have been urging the college administration to clear the outstanding payments, ensure regular disbursal and revise the stipend amount to match those offered in government medical colleges as per Government Order (GO) 59. Frustrated by the administration's inaction, the students resorted to a protest. According to the agitating students, stipends for second-year postgraduates have been pending since September, while first-year students have not received payment for the past three months. They alleged that the college has been paying only Rs 10,000 per month since the first year — an amount they say is grossly insufficient to cover basic expenses. 'We have been requesting an increase in the stipend since our first year,' said Dr Mohammed Ismail, a second-year PG student, speaking to TNIE. 'Even though we managed with RS 10,000 initially, we demanded the amount be revised in line with GO 59. But there has been no response. On top of that, no one in the administration is taking responsibility. We are made to work long hours without fair compensation.'
Fashion Value Chain
an hour ago
- Fashion Value Chain
RenaissThera Achieves Discovery Milestone in Its Oral Obesity Drug Program
RenaissThera Private Limited ('RenaissThera'), a Bengaluru-based biotechnology company, announced a major milestone in its obesity drug discovery program targeting the glucose-dependent insulinotropic polypeptide receptor (GIPR). GIPR, an incretin receptor, is a validated target for peptide-based parenteral therapies where both stimulation and inhibition has shown efficacy in treating obesity and its co-morbidities. RenaissThera is developing novel, oral small molecules, both agonists and antagonists, as a more affordable and convenient alternative aiming to expand access for underserved populations in the global obesity market projected to reach USD 38 billion by 2032. Oral small molecules are more economical to manufacture and distribute than peptide-based obesity drugs. These molecules were designed and screened using proprietary AI and ML based platforms, followed by demonstrating in-vitro activity in cell lines and in-vivo activity to impact GIPR in mice to yield 'Hits'. RenaissThera now is advancing these Hits to the Lead optimization program to select candidates for pre-IND studies. RenaissThera is filing 'Composition of Matter' and utility patents for these oral novel small molecule GIPR modulators and continues to expand its innovation portfolio targeting GIP, GLP-1, and apelin receptors in obesity and diabetes. Its AI-powered Innovation Platform, integrating GenAI and machine learning tools, is accelerating the design and optimization of novel small molecules. 'We are grateful to our investors and collaborators for supporting us in reaching this milestone. Our team is focused on pushing candidates toward IND-readiness next year and we are in active discussions with potential pharma partners and investors interested in our obesity program,' said Dr. Ramkesh Meena, MD, CEO of RenaissThera. RenaissThera's progress was enabled through its collaboration with VedTechBio Research Private Limited which enabled access to its Agentic AI platform RxAgentAI and discovery expertise. 'We are very pleased with the outcomes of our collaboration with RenaissThera. This milestone further validates our platform and capabilities across key therapeutic areas including obesity, Type 2 diabetes, oncology, and inflammation,' said VedTechBio's Managing Director Sudhir Nagarajan. About RenaissThera RenaissThera is a Bengaluru-based biotech company developing affordable, AI-powered novel small-molecule therapies for high-unmet-need diseases like obesity and diabetes. Its goal is to innovate for underserved populations and expand global access to novel therapies. It leverages Indias CRO ecosystem for early-stage R&D to deliver globally relevant innovation. For more information
Mint
2 hours ago
- Mint
Small-cap stock below ₹200 hits 52-week high upper circuit after THIS overseas business update
Small-cap stock below ₹ 200: Aayush Wellness share price hit 52-week high by surging 2 per cent upper circuit in Tuesday's trading session to ₹ 154.05 apiece after the board approved the formation of wholly owned subsidiary in Singapore with an initial capital investment of SGD 10,000. The small-cap stock has gained over 51 per cent in last one month. In last one year, Aayush Wellness stock has given multibagger returns to its investors by ascending over 782 per cent. In a release dated June 9, the company said that this strategic expansion marks a significant step in the company's global growth strategy and will serve as a launchpad for its nutraceutical and healthcare products across the rapidly expanding Southeast Asian markets. 'Our new Singapore-based subsidiary will enable us to tap into one of the world's most dynamic wellness markets, offering greater agility in operations, regulatory efficiency, and direct access to high-growth ASEAN economies. This is a critical step toward building a global wellness brand," Naveena Kumar, Managing Director of Aayush Wellness said. The company further said that the expansion would focus on the following areas - Localizing product offerings to align with regulatory and cultural preferences, forging strategic partnerships and e-commerce distribution channels across ASEAN, driving export growth from India while expanding the company's international brand presence, establishing a regional R&D and innovation hub to adapt to market-specific wellness trends. ' This development is in line with Aayush Wellness Limited's broader mission to deliver science-backed, sustainable, and natural healthcare solutions globally. The company aims to use its new presence in Singapore to not only access markets in Malaysia, Indonesia, Thailand, and Vietnam, but also to establish a foundation for future global partnerships and innovation,' the company said. Disclaimer: This story is for educational purposes only. The views and recommendations above are those of individual analysts or broking companies, not Mint. We advise investors to check with certified experts before making any investment decisions.
